Opal Wealth Advisors, LLC Dexcom Inc Transaction History

Opal Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$110.31 - $140.45 $661 - $842	6 New	6 $0
Q3 2022 Oct 17, 2022	SELL	$76.35 - $94.18 $2,366 - $2,919	-31 Reduced 0.48%	6,387 $514,000
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $327,643 - $640,396	4,819 Added 301.38%	6,418 $478,000
Q1 2022 May 09, 2022	BUY	$94.08 - $130.2 $13,829 - $19,139	147 Added 10.12%	1,599 $818,000
Q4 2021 Jan 31, 2022	BUY	$129.87 - $162.82 $188,571 - $236,414	1,452 New	1,452 $780,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Opal Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Opal Wealth Advisors, LLC with notifications on news.